Secondary Logo

Journal Logo

Institutional members access full text with Ovid®

TWELVE MONTH OUTCOMES WITH BUPRENORPHINE IMPLANTS FOR OPIOID DEPENDENCE

Bailey, G. L.1,*; Ling, W.2; Beebe, K. L.3

Canadian Journal of Addiction: May 2013 - Volume 4 - Issue 2 - p 7–8
Abstracts from the International Society of Addiction Medicine Annual Meeting, Geneva, Switzerland 2012: PDF Only
Buy

1Clinical Assistant Professor of Psychiatry and Human Behavior, Department of Psychiatry and Human Behavior, The Warren Alpert Medical School of Brown University and Director of Research/Medical Director of Dual Diagnosis Unit, Stanley Street Treatment and Resources, Inc.,, Fall River, MA, 2Professor of Psychiatry and Director, Integrated Substance Abuse Programs, Dept. Psychiatry & Biobehavioral Sciences, David Geffen School of Medicine at UCLA, Los Angeles, CA, 3Clinical Development, Titan Pharmaceuticals, Inc., South San Francisco, CA, United States

© 2013 by Lippincott Williams & Wilkins, Inc.
You currently do not have access to this article

To access this article:

Note: If your society membership provides full-access, you may need to login on your society website